relative to increasing transparency in the 340B Drug Pricing Program.
Refer to Interim Study, MA, VV; 03/05/2026; SJ 5
Summary
The bill mandates that hospitals, their practice locations, and contracted pharmacies in the 340B drug pricing program file an annual report on drug use, costs, reimbursements and net savings with the state health department. It also forces claim‑level 340B identifiers on all fee‑for‑service and managed‑care claims and adds rules to stop duplicate discounts. The aim is to make the program’s savings and operations clearer to the public, especially in rural areas.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when SB 477 changes status, plus AI-powered summaries and stage predictions.
Sign up free